Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease

Kejal M Kantarci, Stephen D. Weigand, Ronald Carl Petersen, Bradley F Boeve, David S Knopman, Jeffrey Gunter, Denise Reyes, Maria Shiung, Peter C. O'Brien, Glenn E. Smith, Robert J. Ivnik, Eric George Tangalos, Clifford R Jr. Jack

Research output: Contribution to journalArticle

133 Citations (Scopus)

Abstract

Magnetic resonance (MR)-based volume measurements of atrophy are potential markers of disease progression in patients with amnestic mild cognitive impairment (MCI) and Alzheimer's disease (AD). Longitudinal changes in 1H MR spectroscopy (1H MRS) metabolite markers have not been characterized in MCI subjects. Our objective was to determine the longitudinal 1H MRS metabolite changes in patients with MCI, and AD, and to compare 1H MRS metabolite ratios and ventricular volumes in tracking clinical disease progression in AD. The neuronal integrity marker N-acetylaspartate/creatine ratio declined in MCI and AD patients compared to cognitively normal elderly. The change in 1H MRS metabolite ratios correlated with clinical progression about as strongly as the rate of ventricular expansion, suggesting that 1H MRS metabolite ratios may be useful markers for the progression of AD. Choline/creatine ratio declined in stable MCI, compared to converter MCI patients and cognitively normal elderly, which may be related to a compensatory mechanism in MCI patients who did not to progress to AD.

Original languageEnglish (US)
Pages (from-to)1330-1339
Number of pages10
JournalNeurobiology of Aging
Volume28
Issue number9
DOIs
StatePublished - Sep 2007

Fingerprint

Alzheimer Disease
Magnetic Resonance Spectroscopy
Creatine
Disease Progression
Choline
Cognitive Dysfunction
Atrophy

Keywords

  • H MR spectroscopy
  • H MRS
  • Alzheimer's disease
  • Choline
  • Imaging
  • Longitudinal
  • Mild cognitive impairment
  • N-Acetylaspartate
  • Serial

ASJC Scopus subject areas

  • Clinical Neurology
  • Biological Psychiatry
  • Developmental Neuroscience
  • Neurology
  • Psychology(all)

Cite this

Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease. / Kantarci, Kejal M; Weigand, Stephen D.; Petersen, Ronald Carl; Boeve, Bradley F; Knopman, David S; Gunter, Jeffrey; Reyes, Denise; Shiung, Maria; O'Brien, Peter C.; Smith, Glenn E.; Ivnik, Robert J.; Tangalos, Eric George; Jack, Clifford R Jr.

In: Neurobiology of Aging, Vol. 28, No. 9, 09.2007, p. 1330-1339.

Research output: Contribution to journalArticle

Kantarci, Kejal M ; Weigand, Stephen D. ; Petersen, Ronald Carl ; Boeve, Bradley F ; Knopman, David S ; Gunter, Jeffrey ; Reyes, Denise ; Shiung, Maria ; O'Brien, Peter C. ; Smith, Glenn E. ; Ivnik, Robert J. ; Tangalos, Eric George ; Jack, Clifford R Jr. / Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease. In: Neurobiology of Aging. 2007 ; Vol. 28, No. 9. pp. 1330-1339.
@article{b4d1a8ce9a6649798e24ed650c4c6275,
title = "Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease",
abstract = "Magnetic resonance (MR)-based volume measurements of atrophy are potential markers of disease progression in patients with amnestic mild cognitive impairment (MCI) and Alzheimer's disease (AD). Longitudinal changes in 1H MR spectroscopy (1H MRS) metabolite markers have not been characterized in MCI subjects. Our objective was to determine the longitudinal 1H MRS metabolite changes in patients with MCI, and AD, and to compare 1H MRS metabolite ratios and ventricular volumes in tracking clinical disease progression in AD. The neuronal integrity marker N-acetylaspartate/creatine ratio declined in MCI and AD patients compared to cognitively normal elderly. The change in 1H MRS metabolite ratios correlated with clinical progression about as strongly as the rate of ventricular expansion, suggesting that 1H MRS metabolite ratios may be useful markers for the progression of AD. Choline/creatine ratio declined in stable MCI, compared to converter MCI patients and cognitively normal elderly, which may be related to a compensatory mechanism in MCI patients who did not to progress to AD.",
keywords = "H MR spectroscopy, H MRS, Alzheimer's disease, Choline, Imaging, Longitudinal, Mild cognitive impairment, N-Acetylaspartate, Serial",
author = "Kantarci, {Kejal M} and Weigand, {Stephen D.} and Petersen, {Ronald Carl} and Boeve, {Bradley F} and Knopman, {David S} and Jeffrey Gunter and Denise Reyes and Maria Shiung and O'Brien, {Peter C.} and Smith, {Glenn E.} and Ivnik, {Robert J.} and Tangalos, {Eric George} and Jack, {Clifford R Jr.}",
year = "2007",
month = "9",
doi = "10.1016/j.neurobiolaging.2006.06.018",
language = "English (US)",
volume = "28",
pages = "1330--1339",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease

AU - Kantarci, Kejal M

AU - Weigand, Stephen D.

AU - Petersen, Ronald Carl

AU - Boeve, Bradley F

AU - Knopman, David S

AU - Gunter, Jeffrey

AU - Reyes, Denise

AU - Shiung, Maria

AU - O'Brien, Peter C.

AU - Smith, Glenn E.

AU - Ivnik, Robert J.

AU - Tangalos, Eric George

AU - Jack, Clifford R Jr.

PY - 2007/9

Y1 - 2007/9

N2 - Magnetic resonance (MR)-based volume measurements of atrophy are potential markers of disease progression in patients with amnestic mild cognitive impairment (MCI) and Alzheimer's disease (AD). Longitudinal changes in 1H MR spectroscopy (1H MRS) metabolite markers have not been characterized in MCI subjects. Our objective was to determine the longitudinal 1H MRS metabolite changes in patients with MCI, and AD, and to compare 1H MRS metabolite ratios and ventricular volumes in tracking clinical disease progression in AD. The neuronal integrity marker N-acetylaspartate/creatine ratio declined in MCI and AD patients compared to cognitively normal elderly. The change in 1H MRS metabolite ratios correlated with clinical progression about as strongly as the rate of ventricular expansion, suggesting that 1H MRS metabolite ratios may be useful markers for the progression of AD. Choline/creatine ratio declined in stable MCI, compared to converter MCI patients and cognitively normal elderly, which may be related to a compensatory mechanism in MCI patients who did not to progress to AD.

AB - Magnetic resonance (MR)-based volume measurements of atrophy are potential markers of disease progression in patients with amnestic mild cognitive impairment (MCI) and Alzheimer's disease (AD). Longitudinal changes in 1H MR spectroscopy (1H MRS) metabolite markers have not been characterized in MCI subjects. Our objective was to determine the longitudinal 1H MRS metabolite changes in patients with MCI, and AD, and to compare 1H MRS metabolite ratios and ventricular volumes in tracking clinical disease progression in AD. The neuronal integrity marker N-acetylaspartate/creatine ratio declined in MCI and AD patients compared to cognitively normal elderly. The change in 1H MRS metabolite ratios correlated with clinical progression about as strongly as the rate of ventricular expansion, suggesting that 1H MRS metabolite ratios may be useful markers for the progression of AD. Choline/creatine ratio declined in stable MCI, compared to converter MCI patients and cognitively normal elderly, which may be related to a compensatory mechanism in MCI patients who did not to progress to AD.

KW - H MR spectroscopy

KW - H MRS

KW - Alzheimer's disease

KW - Choline

KW - Imaging

KW - Longitudinal

KW - Mild cognitive impairment

KW - N-Acetylaspartate

KW - Serial

UR - http://www.scopus.com/inward/record.url?scp=34447580083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447580083&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2006.06.018

DO - 10.1016/j.neurobiolaging.2006.06.018

M3 - Article

C2 - 16860440

AN - SCOPUS:34447580083

VL - 28

SP - 1330

EP - 1339

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 9

ER -